Effectiveness and Efficiency of Platelet Rich Plasma in the Treatment of Diabetic Ulcers

Author(s): Raquel Cobos, Felipe Aizpuru, Naiara Parraza, Eduardo Anitua, Gorka Orive

Journal Name: Current Pharmaceutical Biotechnology

Volume 16 , Issue 7 , 2015

Become EABM
Become Reviewer


“There is a growing body of evidence suggesting that wound healing in chronic diabetic foot ulcers is growth factor dependent, and that the therapeutic delivery of these growth factors to wounds topically, has the potential ability to accelerate wound healing in conjunction with conventional wound care”. There is, however, confusion about the utility of platelet rich plasma because the studies that have evaluated them use a wide range of products (different platelet and leukocyte concentrations, different techniques and frequencies of application, very heterogeneous simple, and different endpoints) making almost impossible to compare data and draw conclusions. In this study, we have analyzed the different platelet rich plasma products from a new perspective: cost-efficiency. According to our data, we observe that platelet rich plasma is a cost-effective option that allows faster healing of ulcers, and that should be taken into account in patients with long evolution ulcers.

Keywords: Cost-benefit analysis, skin ulcers, platelet-rich plasma, varicose ulcers.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 27 April, 2015
Page: [630 - 634]
Pages: 5
DOI: 10.2174/138920101607150427111926
Price: $65

Article Metrics

PDF: 55